Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

The TERdeblue-S study is a feasibility study of robotic remote echocardiography, not only in terms of technology but also in terms of its integration into a telemedicine system to improve access to the heart failure management system in the Guadeloupe archipelago. The main objective of this study is to study the agreement of the measurement of the left ventricular ejection fraction (FejVG) between in situ echocardiography (EIS) and two-dimensional remote echocardiography (TER) (distance and volumes).

Eligibility criteria

Qualifiers

Age ≥18 years

Free, informed and written consent signed by the participant and the investigator

Person affiliated or benefiting from a social security scheme.

Systematic cardiovascular check-up or asymptomatic patient with cardiovascular risk factor (hypertension, diabetes, obesity, tobacco, alcohol)

Disqualifiers

Patient requiring urgent cardiological management with transfer to the University Hospital

Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week)

Pregnant women

Trial design

Treatments tested in this trial

  • in situ echocardiography (EIS)
  • two-dimensional remote echocardiography (TER)

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators